Literature DB >> 10554514

[Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

G Hein1, T Eidner, P Oelzner, B Manger.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10554514     DOI: 10.1007/bf03044953

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


× No keyword cloud information.
  76 in total

Review 1.  [Mycophenolate mofetil in comparison with other immunosuppressive drugs].

Authors:  P Schnülle; F J van der Woude
Journal:  Internist (Berl)       Date:  1998-08       Impact factor: 0.743

2.  Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing.

Authors:  A T Masi; G P Chrousos
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

Review 3.  [Immunosuppressive therapeutic modalities in chronic polyarthritis].

Authors:  H M Lorenz; T Geiler; J R Kalden
Journal:  Internist (Berl)       Date:  1997-06       Impact factor: 0.743

4.  Neoral--new cyclosporin for old?

Authors:  M F Somerville; D G Scott
Journal:  Br J Rheumatol       Date:  1997-10

5.  The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

Authors:  J Y Fu; J L Masferrer; K Seibert; A Raz; P Needleman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

6.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

Authors:  P Sambrook; J Birmingham; P Kelly; S Kempler; T Nguyen; N Pocock; J Eisman
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

7.  Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.

Authors:  E González; C de la Cruz; R de Nicoläs; J Egido; G Herrero-Beaumont
Journal:  Agents Actions       Date:  1994-05

8.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

9.  A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

Authors:  M E Weinblatt; J M Kremer; A D Bankhurst; K J Bulpitt; R M Fleischmann; R I Fox; C G Jackson; M Lange; D J Burge
Journal:  N Engl J Med       Date:  1999-01-28       Impact factor: 91.245

10.  Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

Authors:  R I Scheinman; P C Cogswell; A K Lofquist; A S Baldwin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.